BlackRock’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
BlackRock's GRCL Position: Q1 2024 in Review
BlackRock sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 539,973 shares — an estimated $5.42M sold.
BlackRock first reported a position in GRCL in Q1 2021 and held it in 12 quarters. The position peaked at $14.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.
- BlackRock reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- BlackRock sold 539,973 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $5.42M.
- BlackRock first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2021 and held it in 12 quarters.
- BlackRock's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $14.7M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.